Ji Li is an accomplished leader in the biotechnology and pharmaceutical sectors, currently serving as a member of the Board of Directors at Molecular Targeting Technology, Inc. since May 2019 and as President of Nuvax Holdings since February 2018. As a co-founder and President & CEO of Uvax Bio, a role held from March 2018 to January 2025, Ji Li has significantly contributed to the company's strategic direction. Prior experience includes serving as Director at Wilmington PharmaTech Company LLC from January 2013 to September 2018 and Managing Director for M&A, Technology Development, and the Pharmaceutical Division at Feixiang Group from October 2006 to June 2016. Ji Li was also the Group President & CEO during the same tenure and previously served as Vice President of R&D and Technologies at Rhodia Asia Pacific from July 2001 to September 2006. Ji Li holds a Ph.D. in Organic Chemistry from Princeton University, earned between 1989 and 1993.
This person is not in any teams
This person is not in any offices
Molecular Targeting Technology, Inc.
Molecular Targeting Technology, Inc. is a research company based out of 833 Lincoln Ave, West Chester, PA, United States.